On the other hand, enzyme-mediated Kyn elimination (e.g. via kynureninase (KYNase)) has the potential to overcome these limitations, though its efficacy greatly hinges on prolonged catalysis at the tumor site due to similarly fast clearance as small-molecule inhibitors and insufficient accumulation at the target site31,32. This evidence concerns the gene KYNU and neoplasm.